Senti Biosciences (SNTI) Earnings Analysis
Senti Biosciences (SNTI) has no confirmed upcoming earnings date. Last quarter (2026-05-14) it beat with EPS -0.14 USD vs -0.27 USD est (+48.1%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -0.23.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SNTI next report earnings?
No confirmed upcoming earnings date is currently scheduled for SNTI. This page updates as the calendar is published.
SNTI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.14 USD | -0.27 USD | +48.1% | Beat |
| 2026-03-27 | -0.38 USD | -0.43 USD | +11.6% | Beat |
| 2025-11-13 | -0.69 USD | -0.59 USD | -16.9% | Miss |
| 2025-08-07 | -0.56 USD | -0.9 USD | +37.8% | Beat |
| 2025-03-20 | -0.67 USD | -3.13 USD | +78.6% | Beat |
| 2024-11-14 | -6.31 USD | n/a | n/a | n/a |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
SNTI valuation and analyst view
| Trailing P/E | -0.23 |
|---|---|
| Trailing EPS | -1.66433 USD |
| Price / book | 5.32 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (2 buy / 2 hold / 0 sell) |
| Avg price target | 6 USD |
Related research pages
Frequently asked questions
When is Senti Biosciences (SNTI)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for SNTI. This page updates as the calendar is published.
Did SNTI beat earnings last quarter?
In its 2026-05-14 report, SNTI posted EPS of -0.14 USD versus a -0.27 USD estimate — a beat of 48.1%.
What is SNTI's earnings track record?
Over the last 5 reported quarters with consensus data, SNTI beat estimates 4 times (80%).
What is SNTI's current P/E ratio and EPS?
SNTI trades at a trailing P/E of -0.23 on trailing EPS of -1.6643326446480455 USD.
What do analysts rate SNTI?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 6 USD.